No increase in intussusception after RotaTeq immunization

Infants given RotaTeq, a rotavirus vaccine, had no increased risk of intussusception after immunization compared with infants not given RotaTeq, according to the 4-year Vaccine Safety Datalink (VSD) study.

The multiple-site study, conducted in the United States and published earlier this year in the Journal of the American Medical Association, confirmed that there is no increased risk of intussusception with RotaTeq when given to infants aged 4 weeks to 34 weeks.

“The prevalence of rotavirus in hospitalized gastroenteritis in children under 5 years of age is about 39% in India, similar to that in the rest for Asia and the overall worldwide figures.”
-Gagandeep Kang, MD, PhD, professor at Christian Medical College in Vellore, Tamil Nadu, India, and head of Wellcome Trust’s Research Laboratory

An earlier rotavirus vaccine, Rotashield, was withdrawn from the market in 1999 due to...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Infectious Disease, Pediatrics, Primary Care and tagged , , , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.